BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 21457345)

  • 1. Histone deacetylase-1 and -2 expression in mobile tongue squamous cell carcinoma: associations with clinicopathological parameters and patients survival.
    Theocharis S; Klijanienko J; Giaginis C; Rodriguez J; Jouffroy T; Girod A; Alexandrou P; Sastre-Garau X
    J Oral Pathol Med; 2011 Oct; 40(9):706-14. PubMed ID: 21457345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metallothionein expression in mobile tongue squamous cell carcinoma: associations with clinicopathological parameters and patient survival.
    Theocharis S; Klijanienko J; Giaginis C; Rodriguez J; Jouffroy T; Girod A; Point D; Tsourouflis G; Sastre-Garau X
    Histopathology; 2011 Sep; 59(3):514-25. PubMed ID: 22034891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of DNA repair proteins, MSH2, MLH1 and MGMT in mobile tongue squamous cell carcinoma: associations with clinicopathological parameters and patients' survival.
    Theocharis S; Klijanienko J; Giaginis C; Rodriguez J; Jouffroy T; Girod A; Point D; Tsourouflis G; Sastre-Garau X
    J Oral Pathol Med; 2011 Mar; 40(3):218-26. PubMed ID: 21029181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of Hippo pathway effector TAZ in tongue squamous cell carcinoma: correlation with clinicopathological features and patients' prognosis.
    Wei Z; Wang Y; Li Z; Yuan C; Zhang W; Wang D; Ye J; Jiang H; Wu Y; Cheng J
    J Oral Pathol Med; 2013 Nov; 42(10):747-54. PubMed ID: 23551691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of cannabinoid CB1 and CB2 receptors expression in mobile tongue squamous cell carcinoma: associations with clinicopathological parameters and patients' survival.
    Theocharis S; Giaginis C; Alexandrou P; Rodriguez J; Tasoulas J; Danas E; Patsouris E; Klijanienko J
    Tumour Biol; 2016 Mar; 37(3):3647-56. PubMed ID: 26459312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High expression of the histone demethylase LSD1 associates with cancer cell proliferation and unfavorable prognosis in tongue cancer.
    Yuan C; Li Z; Qi B; Zhang W; Cheng J; Wang Y
    J Oral Pathol Med; 2015 Feb; 44(2):159-65. PubMed ID: 25040359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peroxisome proliferator-activated receptor-γ in mobile tongue squamous cell carcinoma: associations with clinicopathological parameters and patients survival.
    Theocharis S; Klijanienko J; Giaginis C; Rodriguez J; Jouffroy T; Girod A; Point D; Tsourouflis G; Satre-Garau X
    J Cancer Res Clin Oncol; 2011 Feb; 137(2):251-9. PubMed ID: 20390425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ephrin receptor (Eph) -A1, -A2, -A4 and -A7 expression in mobile tongue squamous cell carcinoma: associations with clinicopathological parameters and patients survival.
    Theocharis S; Klijanienko J; Giaginis C; Alexandrou P; Patsouris E; Sastre-Garau X
    Pathol Oncol Res; 2014 Apr; 20(2):277-84. PubMed ID: 24022400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fatty acid synthase expression in squamous cell carcinoma of the tongue: clinicopathological findings.
    Silva SD; Perez DE; Nishimoto IN; Alves FA; Pinto CA; Kowalski LP; Graner E
    Oral Dis; 2008 May; 14(4):376-82. PubMed ID: 18410580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Postoperative recurrence-related factors of 125 patients with cT1-2N0 squamous cell carcinoma of the oral tongue].
    Han JM; Wu GH; Zeng ZY; Chen FJ; Chen WK; Li H; Song M; Sun CZ
    Ai Zheng; 2007 Jun; 26(6):661-5. PubMed ID: 17562277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinicopathological features and proliferation markers in tongue squamous cell carcinomas.
    Gueiros LA; Coletta RD; Kowalski LP; Lopes MA
    Int J Oral Maxillofac Surg; 2011 May; 40(5):510-5. PubMed ID: 21277167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extracellular signal-regulated kinase (ERK) expression and activation in mobile tongue squamous cell carcinoma: associations with clinicopathological parameters and patients survival.
    Theocharis S; Kotta-Loizou I; Klijanienko J; Giaginis C; Alexandrou P; Dana E; Rodriguez J; Patsouris E; Sastre-Garau X
    Tumour Biol; 2014 Jul; 35(7):6455-65. PubMed ID: 24682903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of novel oncogenes squamous cell carcinoma-related oncogene and phosphatidylinositol 3-kinase p110alpha in squamous cell carcinoma of the oral tongue.
    Estilo CL; O-Charoenrat P; Ngai I; Patel SG; Reddy PG; Dao S; Shaha AR; Kraus DH; Boyle JO; Wong RJ; Pfister DG; Huryn JM; Zlotolow IM; Shah JP; Singh B
    Clin Cancer Res; 2003 Jun; 9(6):2300-6. PubMed ID: 12796399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FAK and Src expression in mobile tongue squamous cell carcinoma: associations with clinicopathological parameters and patients survival.
    Theocharis S; Klijanienko J; Giaginis C; Alexandrou P; Patsouris E; Sastre-Garau X
    J Cancer Res Clin Oncol; 2012 Aug; 138(8):1369-77. PubMed ID: 22488171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EMMPRIN expression in tongue squamous cell carcinoma.
    Huang Z; Huang H; Li H; Chen W; Pan C
    J Oral Pathol Med; 2009 Jul; 38(6):518-23. PubMed ID: 19473445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression and Clinical Significance of Concomitant FAK/SRC and p-Paxillin in Mobile Tongue Squamous Cell Carcinoma.
    Theocharis S; Kotta-Loizou I; Giaginis C; Alexandrou P; Danas E; Tsourouflis G; Tsoukalas N; Coutts RH; Tasoulas J; Klijanienko J
    Anticancer Res; 2017 Mar; 37(3):1313-1319. PubMed ID: 28314297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Osteopontin as biomarker in early invasion by squamous cell carcinoma in tongue.
    Matsuzaki H; Shima K; Muramatsu T; Ro Y; Hashimoto S; Shibahara T; Shimono M
    J Oral Pathol Med; 2007 Jan; 36(1):30-4. PubMed ID: 17181739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for late cervical lymph node metastases in patients with stage I or II carcinoma of the tongue.
    Kurokawa H; Yamashita Y; Takeda S; Zhang M; Fukuyama H; Takahashi T
    Head Neck; 2002 Aug; 24(8):731-6. PubMed ID: 12203797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Positive and negative regulation of podoplanin expression by TGF-β and histone deacetylase inhibitors in oral and pharyngeal squamous cell carcinoma cell lines.
    Ohta M; Abe A; Ohno F; Hasegawa Y; Tanaka H; Maseki S; Kondo E; Kurita K; Nakanishi H
    Oral Oncol; 2013 Jan; 49(1):20-6. PubMed ID: 22840788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Survival analysis of 229 patients with advanced squamous cell carcinoma of the oral tongue].
    Yang AK; Liu TR; Chen FJ; Ma XF; Guo ZM; Song M; Li QL; Zeng ZY
    Ai Zheng; 2008 Dec; 27(12):1315-20. PubMed ID: 19080001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.